148 related articles for article (PubMed ID: 20541785)
1. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.
Glazer ES; Massey KL; Zhu C; Curley SA
Surgery; 2010 Aug; 148(2):319-24. PubMed ID: 20541785
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles.
Glazer ES; Curley SA
Cancer; 2010 Jul; 116(13):3285-93. PubMed ID: 20564640
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
Glazer ES; Zhu C; Massey KL; Thompson CS; Kaluarachchi WD; Hamir AN; Curley SA
Clin Cancer Res; 2010 Dec; 16(23):5712-21. PubMed ID: 21138869
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
5. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
Cherukuri P; Curley SA
Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608
[TBL] [Abstract][Full Text] [Related]
6. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
Raoof M; Zhu C; Kaluarachchi WD; Curley SA
Int J Hyperthermia; 2012; 28(3):202-9. PubMed ID: 22515341
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
[TBL] [Abstract][Full Text] [Related]
8. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
Bhattacharyya S; Bhattacharya R; Curley S; McNiven MA; Mukherjee P
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14541-6. PubMed ID: 20679244
[TBL] [Abstract][Full Text] [Related]
9. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy.
Raoof M; Corr SJ; Kaluarachchi WD; Massey KL; Briggs K; Zhu C; Cheney MA; Wilson LJ; Curley SA
Nanomedicine; 2012 Oct; 8(7):1096-105. PubMed ID: 22349096
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
[TBL] [Abstract][Full Text] [Related]
12. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
[TBL] [Abstract][Full Text] [Related]
13. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.
Groysbeck N; Stoessel A; Donzeau M; da Silva EC; Lehmann M; Strub JM; Cianferani S; Dembélé K; Zuber G
Nanotechnology; 2019 May; 30(18):184005. PubMed ID: 30650397
[TBL] [Abstract][Full Text] [Related]
15. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
16. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles.
Guo Y; Zhang Z; Kim DH; Li W; Nicolai J; Procissi D; Huan Y; Han G; Omary RA; Larson AC
Int J Nanomedicine; 2013; 8():3437-46. PubMed ID: 24039426
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD30-targeted gold nanoparticles for photothermal therapy of L-428 Hodgkin's cell.
Qu X; Yao C; Wang J; Li Z; Zhang Z
Int J Nanomedicine; 2012; 7():6095-103. PubMed ID: 23269868
[TBL] [Abstract][Full Text] [Related]
18. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue.
Eck W; Craig G; Sigdel A; Ritter G; Old LJ; Tang L; Brennan MF; Allen PJ; Mason MD
ACS Nano; 2008 Nov; 2(11):2263-72. PubMed ID: 19206392
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
El Hallal R; Lyu N; Wang Y
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
[TBL] [Abstract][Full Text] [Related]
20. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
